IndraLab

Statements


USP18 inhibits mutated KRAS. 1 / 1
| 1

reach
"Gain of USP18 expression enhanced (XREF_FIG) and loss of USP18 significantly (P < 0.05) reduced (XREF_FIG and XREF_SUPPLEMENTARY) growth of KRAS mutant lung cancer cell lines."